| 113.2846 1.405 (1.26%) | 09-16 14:13 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 142.96 | 1-year : | 151.78 |
| Resists | First : | 122.4 | Second : | 129.94 |
| Pivot price | 118.13  |
|||
| Supports | First : | 110.19 | Second : | 91.68 |
| MAs | MA(5) : | 112.82 |
MA(20) : | 120.07 |
| MA(100) : | 117.3 |
MA(250) : | 141.48 |
|
| MACD | MACD : | -2 |
Signal : | -0.8 |
| %K %D | K(14,3) : | 17.6 |
D(3) : | 13.8 |
| RSI | RSI(14): 42.2 |
|||
| 52-week | High : | 212 | Low : | 100.84 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ IRTC ] has closed above bottom band by 20.8%. Bollinger Bands are 7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 114.03 - 114.66 | 114.66 - 115.18 |
| Low: | 108.86 - 109.75 | 109.75 - 110.48 |
| Close: | 110.56 - 111.89 | 111.89 - 112.97 |
iRhythm Technologies, Inc. is a digital healthcare enterprise dedicated to offering portable electrocardiogram (ECG) monitoring solutions to individuals in the United States who face the risk of cardiac arrhythmias. Its primary offering, the Zio service, provides a comprehensive ambulatory cardiac monitoring system. This system ingeniously combines a wireless, patch-based, and wearable biosensor—specifically embodied in products like the Zio XT and AT monitors—with a sophisticated cloud-based data analysis platform. These single-use biosensors precisely record a patient's heartbeats and ECG data, thereby enabling medical professionals to effectively oversee patient heart health and accurately diagnose arrhythmias. Furthermore, iRhythm maintains a strategic development partnership with Verily Life Sciences LLC, focused on pioneering future atrial fibrillation screening, detection, and monitoring innovations. Founded in 2006, the company maintains its corporate headquarters in San Francisco, California.
Fri, 21 Aug 2026
iRhythm: The Algorithmic Margin Inflection Changes The Story (NASDAQ:IRTC) - Seeking Alpha
Mon, 17 Aug 2026
Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - Morningstar
Mon, 10 Aug 2026
Why iRhythm (IRTC) Shares Are Trading Lower Today - StockStory
Fri, 07 Aug 2026
Why iRhythm (IRTC) Stock Is Trading Up Today - StockStory
Thu, 06 Aug 2026
iRhythm Holdings, Inc. (IRTC) Tops Q2 Earnings and Revenue Estimates - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 33 (M) |
| Shares Float | 30 (M) |
| Held by Insiders | 1.1 (%) |
| Held by Institutions | 110.8 (%) |
| Shares Short | 2,800 (K) |
| Shares Short P.Month | 3,430 (K) |
| EPS | -0.42 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 5.63 |
| Profit Margin | -1.7 % |
| Operating Margin | 7.9 % |
| Return on Assets (ttm) | 0.6 % |
| Return on Equity (ttm) | -9.7 % |
| Qtrly Rev. Growth | 20.1 % |
| Gross Profit (p.s.) | 17.89 |
| Sales Per Share | 25.04 |
| EBITDA (p.s.) | 0.53 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 86 (M) |
| Levered Free Cash Flow | 82 (M) |
| PE Ratio | -269.6 |
| PEG Ratio | 0 |
| Price to Book value | 20.07 |
| Price to Sales | 4.52 |
| Price to Cash Flow | 43.39 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|